Search research articles
Contact Us
Filters
Showing results (341-350 of 393) with videos related to
Page
of 40
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 15, 2018
Preventing Lck Activation in CAR T Cells Confers Treg Resistance but Requires 4-1BB Signaling for Them to Persist and Treat Solid Tumors in Nonlymphodepleted Hosts
Carter M Suryadevara, Rupen Desai, S Harrison Farber, et al.
Technology in Cancer Research & Treatment
|
April 4, 2012
Stereotactic radiotherapy for malignancies involving the trigeminal and facial nerves
K C Cuneo, T M Zagar, D M Brizel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2013
EGFRvIII mCAR-modified T-cell therapy cures mice with established intracerebral glioma and generates host immunity against tumor-antigen loss
John H Sampson, Bryan D Choi, Luis Sanchez-Perez, et al.
Current Problems in Surgery
|
January 30, 2004
Immunotherapy of surgical malignancies
Michael A Morse, H Kim Lyerly, Timothy M Clay, et al.
The Lancet. Oncology
|
November 8, 2015
Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
Hideho Okada, Michael Weller, Raymond Huang, et al.
Biorxiv : the Preprint Server for Biology
|
October 1, 2025
IL-7-mediated expansion of autologous lymphocytes increases CD8<sup>+</sup> VLA-4 expression and accumulation in glioblastoma models
Kirit Singh, Kelly M Hotchkiss, Sarah L Cook, et al.
The New England Journal of Medicine
|
June 27, 2018
Recurrent Glioblastoma Treated with Recombinant Poliovirus
Annick Desjardins, Matthias Gromeier, James E Herndon, et al.
Plos One
|
March 3, 2012
A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma
John H Sampson, Robert J Schmittling, Gary E Archer, et al.
The Journal of Clinical Investigation
|
April 17, 2025
IL-7-mediated expansion of autologous lymphocytes increases CD8+ VLA-4 expression and accumulation in glioblastoma models
Kirit Singh, Kelly M Hotchkiss, Sarah L Cook, et al.
British Journal of Cancer
|
October 6, 2012
Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients
D A Reardon, J E Herndon, K B Peters, et al.
Page
of 40
Search research articles
Search
Showing results (341-350 of 393) with videos related to
Sort By:
Page
of 40
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 15, 2018
Preventing Lck Activation in CAR T Cells Confers Treg Resistance but Requires 4-1BB Signaling for Them to Persist and Treat Solid Tumors in Nonlymphodepleted Hosts
Carter M Suryadevara, Rupen Desai, S Harrison Farber, et al.
Technology in Cancer Research & Treatment
|
April 4, 2012
Stereotactic radiotherapy for malignancies involving the trigeminal and facial nerves
K C Cuneo, T M Zagar, D M Brizel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2013
EGFRvIII mCAR-modified T-cell therapy cures mice with established intracerebral glioma and generates host immunity against tumor-antigen loss
John H Sampson, Bryan D Choi, Luis Sanchez-Perez, et al.
Current Problems in Surgery
|
January 30, 2004
Immunotherapy of surgical malignancies
Michael A Morse, H Kim Lyerly, Timothy M Clay, et al.
The Lancet. Oncology
|
November 8, 2015
Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
Hideho Okada, Michael Weller, Raymond Huang, et al.
Biorxiv : the Preprint Server for Biology
|
October 1, 2025
IL-7-mediated expansion of autologous lymphocytes increases CD8<sup>+</sup> VLA-4 expression and accumulation in glioblastoma models
Kirit Singh, Kelly M Hotchkiss, Sarah L Cook, et al.
The New England Journal of Medicine
|
June 27, 2018
Recurrent Glioblastoma Treated with Recombinant Poliovirus
Annick Desjardins, Matthias Gromeier, James E Herndon, et al.
Plos One
|
March 3, 2012
A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma
John H Sampson, Robert J Schmittling, Gary E Archer, et al.
The Journal of Clinical Investigation
|
April 17, 2025
IL-7-mediated expansion of autologous lymphocytes increases CD8+ VLA-4 expression and accumulation in glioblastoma models
Kirit Singh, Kelly M Hotchkiss, Sarah L Cook, et al.
British Journal of Cancer
|
October 6, 2012
Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients
D A Reardon, J E Herndon, K B Peters, et al.
Page
of 40